p-chloroamphetamine has been researched along with sertraline in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Browne, RG; Koe, BK; Weissman, A; Welch, WM | 1 |
| Bayer, BM; Pellegrino, TC | 1 |
2 other study(ies) available for p-chloroamphetamine and sertraline
| Article | Year |
|---|---|
Sertraline, 1S,4S-N-methyl-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthylamine, a new uptake inhibitor with selectivity for serotonin.
Topics: 1-Naphthylamine; 5-Hydroxytryptophan; Animals; Behavior, Animal; Blood Pressure; Brain Chemistry; Dogs; Dopamine; Drug Interactions; Female; Hypothermia; Lethal Dose 50; Male; Mice; Mice, Inbred Strains; Monoamine Oxidase Inhibitors; Myocardium; Naphthalenes; Norepinephrine; p-Chloroamphetamine; Parasympatholytics; Rats; Rats, Inbred Strains; Receptors, Adrenergic; Serotonin; Serotonin Antagonists; Sertraline | 1983 |
Specific serotonin reuptake inhibitor-induced decreases in lymphocyte activity require endogenous serotonin release.
Topics: 5-Hydroxytryptophan; Animals; Antidepressive Agents; Cell Division; Desipramine; Dopamine Uptake Inhibitors; Fenclonine; Fluoxetine; Lymphocyte Activation; Lymphocytes; Male; Mitogens; Neurons; p-Chloroamphetamine; Piperazines; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Sertraline | 2000 |